William R Ferrell Selected Research

Microvascular Angina (Cardiac Syndrome X)

6/2006

Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William R Ferrell Research Topics

Disease

11	Inflammation (Inflammations) 08/2021 - 03/2002
6	Arthritis (Polyarthritis) 08/2021 - 01/2003
6	Osteoarthritis 01/2021 - 07/2010
4	Rheumatoid Arthritis 08/2021 - 03/2006
2	Pain (Aches) 08/2021 - 11/2016
2	Rheumatic Diseases (Rheumatism) 01/2018 - 10/2004
2	Synovitis 12/2017 - 10/2012
1	Necrosis 12/2017
1	Experimental Arthritis 06/2013
1	Coronary Disease (Coronary Heart Disease) 09/2007
1	Type 2 Diabetes Mellitus (MODY) 09/2007
1	Obesity 03/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2006
1	Microvascular Angina (Cardiac Syndrome X) 06/2006
1	Musculoskeletal Pain 10/2004
1	Joint Instability (Joint Laxity) 10/2004
1	Body Weight (Weight, Body) 06/2004
1	Hyperemia 01/2003
1	Maternal Obesity 09/2002
1	Dyslipidemias (Dyslipidemia) 09/2002
1	Hyperinsulinism (Hyperinsulinemia) 09/2002

Drug/Important Bio-Agent (IBA)

6	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 01/2003
3	PAR-2 ReceptorIBA 01/2021 - 11/2010
3	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2018 - 06/2006
3	Triglycerides (Triacylglycerol)IBA 07/2009 - 09/2003
2	Losartan (Cozaar)FDA LinkGeneric 08/2021 - 06/2013
2	Type 1 Angiotensin ReceptorIBA 08/2021 - 01/2018
2	matriptaseIBA 01/2021 - 07/2010
2	Serine Proteases (Serine Protease)IBA 12/2017 - 07/2010
2	CytokinesIBA 10/2012 - 03/2007
2	Monoclonal AntibodiesIBA 11/2010 - 03/2006
2	Proteinase-Activated ReceptorsIBA 06/2007 - 03/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007 - 03/2006
1	Angiotensin II Type 1 Receptor BlockersIBA 08/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Angiotensin IIIBA 01/2018
1	hepsinIBA 12/2017
1	AngiotensinsIBA 06/2013
1	1- 3- methylbutyryl- N4- 6- aminohexanoyl- piperazineIBA 10/2012
1	LipidsIBA 07/2009
1	HDL CholesterolIBA 07/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2007
1	CarbohydratesIBA 09/2007
1	Vasodilator Agents (Vasodilators)IBA 09/2007
1	von Willebrand FactorIBA 03/2007
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2007
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 03/2007
1	Interleukin-10 (Interleukin 10)IBA 03/2007
1	C-Reactive ProteinIBA 03/2007
1	Interleukin-6 (Interleukin 6)IBA 03/2007
1	Cell Adhesion Molecule-1IBA 03/2007
1	Plasminogen InactivatorsIBA 03/2007
1	CholesterolIBA 06/2006
1	LeptinIBA 11/2004
1	Lipoproteins (Lipoprotein)IBA 11/2004
1	Insulin (Novolin)FDA Link 11/2004
1	Indicators and Reagents (Reagents)IBA 10/2004
1	Prostaglandins EIBA 06/2004
1	ProstaglandinsIBA 06/2004
1	NitritesIBA 06/2004
1	NitratesIBA 06/2004
1	Indomethacin (Indometacin)FDA LinkGeneric 06/2004
1	4- (5- (4- chlorophenyl)- 3- (trifluoromethyl)- 1H- pyrazol- 1- yl)benzenesulfonamideIBA 06/2004
1	2- furoyl- leucyl- isoleucyl- glycyl- lysyl- valineIBA 01/2003
1	Glucose (Dextrose)FDA LinkGeneric 09/2002
1	Protein Isoforms (Isoforms)IBA 03/2002
1	CarrageenanIBA 03/2002
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2002

Therapy/Procedure

2	Intra-Articular Injections 01/2003 - 03/2002
1	Therapeutics 03/2006
1	Biological Therapy 03/2006